PT. Penta Valent Tbk (PEVE.JK)
- Previous Close
212.00 - Open
214.00 - Bid 216.00 x --
- Ask 210.00 x --
- Day's Range
206.00 - 214.00 - 52 Week Range
135.00 - 216.00 - Volume
2,193,900 - Avg. Volume
964,881 - Market Cap (intraday)
374.311B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. The company offers over the counter drug products; medical support devices, such as blood pressure monitors, nebulizer, kateter, and others; reaction materials, including blood sugar tests, pregnancy tests, or rapid tests for Covid19, drug tests, and others; and food supplements comprising minerals and nutrients. It also provides products for beauty and skin care, including makeup, perfume, skin nutrition, and other products; and daily cleaning and hygiene equipment and supplies, such as soaps, shampoos, toothpastes, lotions, and others. The company distributes its products to government hospitals, private hospitals, drug stores, medical device stores, clinics, and pharmacies. PT. Penta Valent Tbk was founded in 1968 and is headquartered in Kebon Jeruk, Indonesia.
www.pentavalent.co.id1,019
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: PEVE.JK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PEVE.JK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PEVE.JK
Valuation Measures
Market Cap
374.31B
Enterprise Value
374.31B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.46%
Return on Assets (ttm)
3.71%
Return on Equity (ttm)
19.09%
Revenue (ttm)
2.48T
Net Income Avi to Common (ttm)
36.17B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
4.49B
Total Debt/Equity (mrq)
33.55%
Levered Free Cash Flow (ttm)
-69.72B
Company Insights: PEVE.JK
PEVE.JK does not have Company Insights